Study of ARO-MAPT-SC in Healthy Participants and Participants With Early Alzheimer's Disease

计划入组 112 人 · 首次发布于 2025 年 10 月 27 日

Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease

计划入组 78 人 · 首次发布于 2022 年 3 月 23 日

Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations

计划入组 7 人 · 首次发布于 2016 年 2 月 8 日

ARO-MAPT-SC

ARO-PNPLA3

ARO-SOD1

Arrowhead Pharmaceuticals

United States

RAPT Therapeutics

United States

ACO

Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials

Arrowhead Seeks FDA Approval for Plozasiran in Familial Chylomicronemia Syndrome

Arrowhead Pharmaceuticals Achieves FDA Approval for Rodemplo, Reports Strong Financial Turnaround